Schedule H1 — India's Stricter Controls on Antibiotics and Habit-Forming Drugs
A comprehensive guide to Schedule H1 drugs in India, including the complete list of controlled antibiotics, benzodiazepines, opioids, and anti-TB medications.
Page 37 of 44.
A comprehensive guide to Schedule H1 drugs in India, including the complete list of controlled antibiotics, benzodiazepines, opioids, and anti-TB medications.
A comprehensive guide to Schedule X drugs in India, the most heavily controlled pharmaceutical category reserved for narcotics and high-abuse substances.
A comprehensive educational breakdown of the Narcotic Drugs and Psychotropic Substances Act, its punishment tiers, and enforcement by the NCB in India.
An educational analysis of the growing prescription drug abuse epidemic in India, covering the most commonly abused drug categories, statistics, and awareness resources.
An educational guide on the legal consequences of forging prescriptions using AI tools under the IPC/BNS, NDPS Act, and Drugs and Cosmetics Act in India.
An exhaustive, research-backed guide to Peer-to-Peer lending platforms in India covering RBI regulations, NPA rates, platform reviews, tax implications, and risk analysis.
A comprehensive guide explaining the mechanics of Peer-to-Peer lending in India, how money flows through escrow accounts, and how lenders earn returns.
A comprehensive guide to the RBI's regulatory framework for P2P lending in India, including the transformative August 2024 rule changes that banned guaranteed returns.
An in-depth review of India's major RBI-registered P2P lending platforms with real NPA data, fee structures, and investor experience analysis.
Understanding default rates, NPA calculations, recovery mechanisms, and worst-case scenarios in Indian P2P lending with real data.
A complete guide to the tax implications of P2P lending interest income in India, covering Section 194A, Income from Other Sources, advance tax, and ITR filing.
A research-backed comparison of P2P lending, bank FDs, and mutual funds in India covering returns, risk, liquidity, regulation, and portfolio allocation.